Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Daiichi Sankyo
Harvard Business School
Federal Trade Commission
Cantor Fitzgerald
US Army

Generated: November 19, 2017

DrugPatentWatch Database Preview

IDAMYCIN Drug Profile

« Back to Dashboard

Which patents cover Idamycin, and when can generic versions of Idamycin launch?

Idamycin is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in IDAMYCIN is idarubicin hydrochloride. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.

Medical Subject Heading (MeSH) Categories for IDAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
idarubicin hydrochloride
INJECTABLE;INJECTION050661-002Sep 27, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
idarubicin hydrochloride
INJECTABLE;INJECTION050734-001Feb 17, 1997APRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
idarubicin hydrochloride
INJECTABLE;INJECTION050661-001Sep 27, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
idarubicin hydrochloride
INJECTABLE;INJECTION050661-003Apr 25, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
Federal Trade Commission
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus